MarketPeel
Insider Trading Intelligence
Pricing
…
SS

Scott Thomas Smith

ASND
EVP & CHIEF FINANCIAL OFFICER · ASCENDIS PHARMA A/S · CIK 0001965550
FILING MIX · LIFETIME100%/0%
BUYS
2
SELLS
0
TOTAL VALUE
$77.7K
COMPANIES
1
ACTIVE SINCE
May 2026
HOLDINGS NOW
4,367
AVG SELL PX
—
TRADE KIND
SHOWING 2 / 2
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Scott Thomas Smith. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
ASND · 4,367 shares · as of Jun 2, 2026
01,0922,1843,2754,367SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2026
FLOW · 2 buys / 0 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
ASND
ASCENDIS PHARMA A/S
PURCHASE
EVP & Chief Financial Officer
100$219.00$21.9K4,367Jun 2, 2026Jun 2, 2026 ↗
ASND
ASCENDIS PHARMA A/S
PURCHASE
EVP & Chief Financial Officer
250$223.32$55.8K4,267May 29, 2026Jun 1, 2026 ↗
Other insiders · ASND
Loading peer insiders…
About this filer
CIK 0001965550
ROLE
EVP & Chief Financial Officer
PRIMARY
ASND
COMPANIES
1
ACTIVE SINCE
May 2026
MARKETPEEL · /INSIDER/0001965550DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback